Europe Nootropics Market Size & Outlook, 2021-2030

The nootropics market in Europe is expected to reach a projected revenue of US$ 2,475.6 million by 2030. A compound annual growth rate of 14.7% is expected of Europe nootropics market from 2022 to 2030.
Revenue, 2021 (US$M)
$721.0
Forecast, 2030 (US$M)
$2,475.6
CAGR, 2022 - 2030
14.7%
Report Coverage
Europe

Europe nootropics market highlights

  • The Europe nootropics market generated a revenue of USD 721.0 million in 2021.
  • The market is expected to grow at a CAGR of 14.7% from 2022 to 2030.
  • In terms of segment, capsules/tablets was the largest revenue generating form in 2021.
  • Drinks is the most lucrative form segment registering the fastest growth during the forecast period.
  • Country-wise, Italy is expected to register the highest CAGR from 2022 to 2030.


Europe data book summary

Market revenue in 2021USD 721.0 million
Market revenue in 2030USD 2,475.6 million
Growth rate14.7% (CAGR from 2021 to 2030)
Largest segmentCapsules/tablets
Fastest growing segmentDrinks
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCapsules/Tablets, Powder, Drinks
Key market players worldwideReckitt Benckiser Group PLC, Mental Mojo, Noocube, Mind Lab, truBrain, Nooflux, Zhou Nutrition, Kimera Koffee


Other key industry trends

  • In terms of revenue, Europe region accounted for 21.6% of the global nootropics market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,460.0 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nootropics Market Companies

Name Profile # Employees HQ Website

Europe nootropics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nootropics market will help companies and investors design strategic landscapes.


Capsules/tablets was the largest segment with a revenue share of 50.85% in 2021. Horizon Databook has segmented the Europe nootropics market based on capsules/tablets, powder, drinks covering the revenue growth of each sub-segment from 2018 to 2030.


Nootropics were first synthesized in Europe. Increasing consumer preference for naturally derived nootropics over synthetic supplements is expected to create growth opportunities for key market players. Furthermore, a growing choice of smart drugs among students to cope with the stress of examinations is anticipated to boost the market growth. 

Reasons to subscribe to Europe nootropics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe nootropics market databook

  • Our clientele includes a mix of nootropics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe nootropics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe nootropics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe nootropics market size, by country, 2018-2030 (US$M)

Europe Nootropics Market Outlook Share, 2021 & 2030 (US$M)

Europe nootropics market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more